The discriminatory Executive Order bars Syrian refugees from entering the United States indefinitely, suspends all refugee admissions for 120 days, imposes bans on refugees on the basis of their religion, and blocks citizens of seven Muslim-majority countries, refugees or otherwise, from entering the United States for 90 days: Iran, Iraq, Libya, Somalia, Sudan, Syria and Yemen.
Oxfam praised President Barack Obama and President Xi Jinping for officially joining their countries to the Paris climate agreement today.
De-risking’ refers to financial institutions closing the accounts of clients perceived as high risk for money laundering or terrorist financing abuse, namely money service businesses, non-profit organizations, correspondent banks and foreign embassies. This report explores the linkages between bank de-risking and the ascendance of the risk-based approach to anti-money laundering and countering the financing of terrorism (AML/CFT).
The joint US-China statement on new domestic policy commitments and a vision for a global climate change deal underscores the importance the world’s two largest emitters place on solving the climate crisis, says Oxfam, but collective action is needed.
We are concerned about the potential destructive impact of the Transatlantic Trade and Investment Partnership on a number of issues, particularly on developing countries.
In response to the announcement from US President Barac
The European Commission is putting the interests of multinational drug companies above those of millions of people with no access to affordable life-saving medicines, warn Oxfam and Health Action International.
The Control Arms Coalition welcomed today’s signing of the Arms Trade Treaty by the United States.
On September 25, 2013, US Secretary of State John Kerry signed the Arms Trade Treaty (ATT).
Despite commitment to end AIDS, the US government is introducing stronger intellectual property rules through trade agreements and bilateral pressure that will undermine the fight against AIDS by devastating the ability of developing countries to access affordable anti-retroviral medicines.